Range
9.69 - 10.04
Vol / Avg.
308.5K/603.1K
Div / Yield
-
52 Wk
4.46 - 16.6
Mkt Cap
566.8M
Payout Ratio
-
Open
9.85
P/E
-
EPS
-0.44
Shares
57.5M
Outstanding
57.5M
Total Float
51.2M
Benzinga - Jul 1, 2021, 1:41PM
Benzinga - Jul 1, 2021, 7:00AM
Benzinga - Jun 28, 2021, 9:16AM
Benzinga - Jun 28, 2021, 7:41AM
Benzinga - Jun 28, 2021, 7:02AM
Benzinga - Jun 4, 2021, 7:08AM
Benzinga - Jun 1, 2021, 7:08AM
Benzinga - May 27, 2021, 7:04AM
Benzinga - May 20, 2021, 1:54PM
Benzinga - May 20, 2021, 11:37AM
Benzinga - May 13, 2021, 2:10PM
Benzinga - May 13, 2021, 7:09AM
Benzinga - May 11, 2021, 2:55PM
Benzinga - May 11, 2021, 12:44PM
Benzinga - May 11, 2021, 12:38PM
Benzinga - Apr 22, 2021, 10:59AM
Benzinga - Apr 15, 2021, 4:38PM
Benzinga - Apr 15, 2021, 4:16PM
Benzinga - Apr 6, 2021, 8:45AM
Benzinga - Mar 18, 2021, 8:53AM
load more
Sector: Health Care.Industry: Biotechnology
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-12
REV
Q1 2021Est.ActualSurprise
EPS-0.500-0.330 0.1700
REV7.110M16.349M9.239M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
DTILPrecision BioSciences-0.8%566.8M

Precision BioSciences Frequently Asked Questions

Q

How do I buy Precision BioSciences (DTIL) stock?

A

You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Precision BioSciences's (DTIL) competitors?

A

Other companies in Precision BioSciences’s space includes: Molecular Partners (NASDAQ:MOLN), Chinook Therapeutics (NASDAQ:KDNY), Eagle Pharmaceuticals (NASDAQ:EGRX), Aligos Therapeutics (NASDAQ:ALGS) and Adaptimmune Therapeutics (NASDAQ:ADAP).

Q

What is the target price for Precision BioSciences (DTIL) stock?

A

The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by JonesTrading on February 24, 2021. The analyst firm set a price target for 27.00 expecting DTIL to rise to within 12 months (a possible 173.83% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Precision BioSciences (DTIL)?

A

The stock price for Precision BioSciences (NASDAQ: DTIL) is $9.86 last updated Fri Jul 30 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Precision BioSciences (DTIL) pay a dividend?

A

There are no upcoming dividends for Precision BioSciences.

Q

When is Precision BioSciences (NASDAQ:DTIL) reporting earnings?

A
Precision BioSciences’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is Precision BioSciences (DTIL) going to split?

A

There is no upcoming split for Precision BioSciences.

Q

What sector and industry does Precision BioSciences (DTIL) operate in?

A

Precision BioSciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.